-
December 2007 FDA “Patient Safety News” Videos For Doctors Online
Covers Sprint Fidelis Cardiac Leads, Byetta, And Bisphosphonates Such As Fosamax (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily for…
-
FDA Expected To Comment On Its Safety Evaluation Of Nexium And Prilosec In December 2007
Agency’s Follow-Up On Its August 2007 "Early Communication" About These Heartburn Drugs Is Late, But Just In Time For Christmas Dinner (Posted by Tom Lamb at DrugInjuryWatch.com) As reported previously, in early August 2007…
-
Mixed Reactions To Avandia’s Revised Warning In November 2007 About Risk Of Heart Attacks
Drug Safety Experts And FDA Officials Discuss Avandia And The New Black-Box Warning (Posted by Tom Lamb at DrugInjuryWatch.com) On November 14, 2007 the FDA issued a news release entitled "FDA Adds Boxed Warning…
-
November 2007 FDA Advisory Panel Recommends That Serevent And Advair Get Stronger Warnings About Use By Children
Some Panel Members Want Serevent Withdrawn From Market; FDA And GSK Say Asthma Drug Recall Is Not Appropriate (Posted by Tom Lamb at DrugInjuryWatch.com) On November 28, 2007 an FDA pediatric advisory panel recommended…
-
FDA Report Says Popular Asthma Drugs Serevent And Advair May Have Deadly Side Effects For Some Children
November 2007 Advisory Panel Meeting To Consider Safety of These Glaxo Drugs As Well As Novartis’ Foradil (Posted by Tom Lamb at DrugInjuryWatch.com) An October 24, 2007 FDA staff report about Serevent (SUBJECT: 1-year…
-
FDA Announces In November 2007 That It Will Investigate Possible Link Between Maxipime And Increased Risk Of Death
A Medical Journal Article Published In May 2007 Suggested This Emerging Drug Safety Issue; Why Was There A Six-Month Delay In Starting This FDA Investigation? (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-November 2007…